Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

Y Bai, W Cui, Y Xin, X Miao, MT Barati, C Zhang… - Journal of molecular and …, 2013 - Elsevier
This study was to investigate whether sulforaphane (SFN) can prevent diabetic
cardiomyopathy. Type 1 diabetes was induced in FVB mice by multiple intraperitoneal …
被引用次数：296 相关文章

[引用][C] Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

Y Bai, W Cui, Y Xin, X Miao, MT Barati… - Journal of Molecular …, 2013 - cir.nii.ac.jp
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of
Nrf2 expression and transcription activation | CiNii Research CiNii 国立情報学研究所 学術 …

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

Y Bai, W Cui, Y Xin, X Miao, MT Barati, C Zhang… - Journal of Molecular and …, 2013 - infona.pl
This study was to investigate whether sulforaphane (SFN) can prevent diabetic
cardiomyopathy. Type 1 diabetes was induced in FVB mice by multiple intraperitoneal …

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

Y Bai, W Cui, Y Xin, X Miao… - … of molecular and …, 2013 - pubmed.ncbi.nlm.nih.gov
This study was to investigate whether sulforaphane (SFN) can prevent diabetic
cardiomyopathy. Type 1 diabetes was induced in FVB mice by multiple intraperitoneal …

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.

Y Bai, W Cui, Y Xin, X Miao, MT Barati… - Journal of Molecular …, 2013 - europepmc.org
This study was to investigate whether sulforaphane (SFN) can prevent diabetic
cardiomyopathy. Type 1 diabetes was induced in FVB mice by multiple intraperitoneal …